Company Filing History:
Years Active: 2015-2021
Title: Kristen Mae Hege: Innovator in Cancer Treatment
Introduction
Kristen Mae Hege is a prominent inventor based in Burlingame, CA (US). She has made significant contributions to the field of cancer treatment, holding a total of 14 patents. Her innovative approaches focus on utilizing TOR kinase inhibitors to combat various forms of cancer.
Latest Patents
Among her latest patents, one addresses the treatment of cancer with TOR kinase inhibitors. This patent outlines methods for treating or preventing solid tumors, non-Hodgkin lymphoma, or multiple myeloma by administering an effective amount of a TOR kinase inhibitor to patients. Another notable patent involves the treatment of hepatocellular carcinoma characterized by hepatitis B virus infection. This patent describes methods for treating and/or preventing hepatocellular carcinoma (HCC) by administering a specific compound to patients suffering from HCC associated with HBV infection.
Career Highlights
Kristen has worked with several reputable companies throughout her career, including Signal Pharmaceuticals, Inc. and Celgene Corporation. Her work in these organizations has allowed her to develop and refine her innovative ideas in cancer treatment.
Collaborations
Some of her notable coworkers include Heather K Raymon and Rajesh Chopra. Their collaborative efforts have contributed to advancing research and development in the field of oncology.
Conclusion
Kristen Mae Hege's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents and collaborations highlight her dedication to improving patient outcomes through scientific advancements.